Symbols / PTPI $0.01 +0.00% Petros Pharmaceuticals, Inc.

Healthcare • Drug Manufacturers - Specialty & Generic • United States • PNK
PTPI Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO —
Exch · Country PNK · United States
Market Cap 338.98K
Enterprise Value -4.80M
Income -50.10M
Sales —
FCF (ttm) -12.78M
Book/sh 0.08
Cash/sh 0.12
Employees 3
Insider 10d —
IPO Dec 02, 2020
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E -0.01
PEG —
P/S —
P/B 0.10
P/C —
EV/EBITDA 2.65
EV/Sales —
Quick Ratio 2.24
Current Ratio 2.25
Debt/Eq —
LT Debt/Eq —
EPS (ttm) -1.79
EPS next Y -1.09
EPS Growth —
Revenue Growth —
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2024-11-13
Earnings (prior) 2024-11-13
ROA -36.72%
ROE —
ROIC —
Gross Margin 0.00%
Oper. Margin 0.00%
Profit Margin 0.00%
Shs Outstand 42.37M
Shs Float 36.25M
Insider Own 7.18%
Instit Own 5.70%
Short Float 25.07%
Short Ratio 0.17
Short Interest 493.83K
52W High 2.62
vs 52W High -99.70%
52W Low 0.00
vs 52W Low 300.00%
Beta 1.66
Impl. Vol. —
Rel Volume 0.03
Avg Volume 108.84K
Volume 3.40K
Target (mean) —
Tgt Median —
Tgt Low —
Tgt High —
# Analysts —
Recom None
Prev Close $0.01
Price $0.01
Change 0.00%
About

Petros Pharmaceuticals, Inc., a healthcare technology company, focuses on developing and licensing proprietary SaaS platform and Software as a medical device web application designed to assist pharmaceutical companies. The company is based in New York, New York.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$0.01
Latest analyst target
3. DCF / Fair value
$-5.43
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.01
Low
—
High
—
Mean
—

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2023-12-08 init Maxim Group — → Buy $4
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-01-02 WALKER WAYNE REMELL Director — 500,000 — —
2026-01-02 BERNSTEIN BRUCE T. Director — 1,875,000 — —
2026-01-02 BOCTOR FADY President — 500,000 — —
2025-02-19 WALKER WAYNE REMELL Director — 150,000 — —
2025-02-19 BERNSTEIN BRUCE T. Director — 300,000 — —
2025-02-19 BOCTOR FADY President — 450,000 — —
2025-02-19 ARNOLD MITCHELL Officer — 150,000 — —
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
0.00
0.00
-100.00%
5.82
-2.83%
5.99
Operating Revenue
0.00
0.00
-100.00%
5.82
-2.83%
5.99
Cost Of Revenue
—
1.21
-25.66%
1.63
-28.75%
2.29
Reconciled Cost Of Revenue
—
1.10
-26.61%
1.50
-31.00%
2.17
Gross Profit
0.00
0.00
-100.00%
4.19
+13.19%
3.70
Operating Expense
4.64
+0.31%
4.63
-69.06%
14.95
-23.50%
19.55
Research And Development
—
2.62
+8.55%
2.41
+38.43%
1.74
Selling General And Administration
4.64
+0.31%
4.63
-50.04%
9.26
-24.14%
12.21
Total Expenses
4.64
+0.31%
4.63
-72.10%
16.58
-24.05%
21.84
Operating Income
-4.64
-0.31%
-4.63
+57.01%
-10.76
+32.08%
-15.85
Total Operating Income As Reported
—
-17.68
-29.83%
-13.62
+31.63%
-19.92
EBITDA
-4.64
-0.31%
-4.63
-9.85%
-4.21
+69.31%
-13.73
Normalized EBITDA
-4.53
+44.65%
-8.18
+54.37%
-17.92
-166.46%
-6.73
Reconciled Depreciation
—
2.94
-13.80%
3.42
-40.25%
5.72
EBIT
-4.64
-0.31%
-4.63
+39.34%
-7.63
+60.77%
-19.44
Total Unusual Items
-0.12
-103.26%
3.55
-74.10%
13.71
+295.84%
-7.00
Total Unusual Items Excluding Goodwill
-0.12
-103.26%
3.55
-74.10%
13.71
+295.84%
-7.00
Special Income Charges
—
-7.38
0.00
+100.00%
-7.46
Impairment Of Capital Assets
—
7.38
0.00
-100.00%
7.46
Net Income
1.91
+113.36%
-14.32
-75.41%
-8.16
+59.26%
-20.04
Pretax Income
-4.50
-538.15%
-0.71
+91.36%
-8.16
+59.26%
-20.04
Net Non Operating Interest Income Expense
0.26
-30.89%
0.37
+1885.03%
-0.02
+96.42%
-0.58
Interest Expense Non Operating
—
0.56
+4.62%
0.54
-10.05%
0.60
Net Interest Income
0.26
-30.89%
0.37
+1885.03%
-0.02
+96.42%
-0.58
Interest Expense
—
0.56
+4.62%
0.54
-10.05%
0.60
Interest Income Non Operating
0.26
-30.89%
0.37
-27.86%
0.52
+3530.48%
0.01
Interest Income
0.26
-30.89%
0.37
-27.86%
0.52
+3530.48%
0.01
Other Income Expense
-0.12
-103.26%
3.55
+35.50%
2.62
+172.58%
-3.61
Other Non Operating Income Expenses
—
—
-11.09
-427.11%
3.39
Gain On Sale Of Security
-0.12
-103.26%
3.55
-74.10%
13.71
+2880.22%
0.46
Tax Provision
0.00
0.00
0.00
0.00
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
1.91
+113.36%
-14.32
-75.41%
-8.16
+59.26%
-20.04
Net Income From Continuing Operation Net Minority Interest
-4.50
-538.15%
-0.71
+91.36%
-8.16
+59.26%
-20.04
Net Income From Continuing And Discontinued Operation
1.91
+113.36%
-14.32
-75.41%
-8.16
+59.26%
-20.04
Net Income Continuous Operations
-4.50
-538.15%
-0.71
+91.36%
-8.16
+59.26%
-20.04
Net Income Discontinuous Operations
6.41
+147.11%
-13.61
—
—
Normalized Income
-4.38
-3.04%
-4.26
+80.55%
-21.87
-67.76%
-13.04
Net Income Common Stockholders
-43.69
-63.04%
-26.80
-93.98%
-13.81
+31.06%
-20.04
Otherunder Preferred Stock Dividend
44.63
+338.82%
10.17
+110.57%
4.83
0.00
Diluted EPS
—
-83.47
+47.42%
-158.75
+34.40%
-242.00
Basic EPS
—
-83.47
+47.42%
-158.75
+34.40%
-242.00
Basic Average Shares
—
0.32
+268.84%
0.09
+5.11%
0.08
Diluted Average Shares
—
0.32
+268.84%
0.09
+5.11%
0.08
Diluted NI Availto Com Stockholders
-43.69
-63.04%
-26.80
-93.98%
-13.81
+31.06%
-20.04
Depreciation Amortization Depletion Income Statement
—
2.83
-13.76%
3.28
-41.36%
5.60
Depreciation And Amortization In Income Statement
—
2.83
-13.76%
3.28
-41.36%
5.60
Net Income Extraordinary
6.97
0.00
—
—
Preferred Stock Dividends
0.97
-57.80%
2.31
+180.98%
0.82
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
5.16
-51.45%
10.64
-68.53%
33.80
+4.24%
32.42
Current Assets
5.16
-29.21%
7.29
-64.23%
20.39
+39.01%
14.67
Cash Cash Equivalents And Short Term Investments
5.14
+198.88%
1.72
-87.11%
13.34
+41.49%
9.43
Cash And Cash Equivalents
5.14
+198.88%
1.72
-87.11%
13.34
+41.49%
9.43
Cash Financial
—
—
13.34
+41.49%
9.43
Receivables
—
0.42
-81.31%
2.23
+5.49%
2.11
Accounts Receivable
—
0.42
-81.31%
2.23
+5.49%
2.11
Gross Accounts Receivable
—
0.58
-79.86%
2.89
+4.69%
2.76
Allowance For Doubtful Accounts Receivable
—
-0.17
+74.99%
-0.66
-2.10%
-0.65
Other Receivables
—
—
—
—
Inventory
—
1.35
-16.18%
1.61
-11.28%
1.82
Raw Materials
—
1.26
-11.62%
1.43
-9.18%
1.57
Finished Goods
—
0.09
-52.34%
0.18
-25.03%
0.24
Prepaid Assets
—
1.81
-24.53%
2.40
+366.99%
0.51
Assets Held For Sale Current
0.00
-100.00%
5.57
—
—
Other Current Assets
0.03
+2936.84%
0.00
-99.89%
0.82
+1.74%
0.80
Total Non Current Assets
0.00
-100.00%
3.34
-75.08%
13.41
-24.49%
17.75
Net PPE
—
0.14
-46.45%
0.26
-35.82%
0.40
Gross PPE
—
0.14
-46.45%
0.26
-35.82%
0.40
Properties
—
0.00
0.00
0.00
Buildings And Improvements
—
—
—
0.36
Machinery Furniture Equipment
—
0.02
-20.75%
0.03
-26.09%
0.04
Leases
—
0.11
-49.73%
0.23
-36.88%
0.36
Goodwill And Other Intangible Assets
—
3.20
-64.28%
8.97
-26.73%
12.24
Other Non Current Assets
—
3.34
-20.04%
4.18
-18.25%
5.11
Total Liabilities Net Minority Interest
2.29
-87.33%
18.10
-15.07%
21.32
+35.61%
15.72
Current Liabilities
2.29
-87.28%
18.03
+67.38%
10.77
+52.39%
7.07
Payables And Accrued Expenses
0.23
-73.80%
0.86
-86.52%
6.41
+27.82%
5.01
Payables
0.08
-89.03%
0.76
-57.28%
1.79
-8.79%
1.96
Accounts Payable
0.08
-89.03%
0.76
-55.39%
1.71
-5.16%
1.81
Other Payable
—
0.07
-2.58%
0.08
-51.17%
0.16
Current Accrued Expenses
0.14
+43.00%
0.10
-97.84%
4.62
+51.34%
3.05
Pensionand Other Post Retirement Benefit Plans Current
—
0.00
-100.00%
0.67
+55.60%
0.43
Current Debt And Capital Lease Obligation
—
7.31
+470.48%
1.28
+4.02%
1.23
Current Debt
—
7.25
+526.75%
1.16
+6.14%
1.09
Current Capital Lease Obligation
—
0.06
-50.06%
0.13
-12.17%
0.14
Current Deferred Liabilities
2.07
+8.17%
1.91
-6.74%
2.05
0.00
Current Deferred Revenue
2.07
+8.17%
1.91
-6.74%
2.05
0.00
Other Current Liabilities
0.00
-99.99%
15.25
+4042.17%
0.37
-6.74%
0.39
Total Non Current Liabilities Net Minority Interest
0.00
-100.00%
0.08
-99.29%
10.55
+21.90%
8.65
Liabilities Heldfor Sale Non Current
0.00
-100.00%
0.08
—
—
Long Term Debt And Capital Lease Obligation
—
0.08
-98.92%
7.00
-19.14%
8.65
Long Term Debt
—
—
6.86
-18.25%
8.39
Long Term Capital Lease Obligation
—
0.08
-45.35%
0.14
-47.59%
0.26
Stockholders Equity
2.87
+138.44%
-7.47
-159.84%
12.48
-25.28%
16.70
Common Stock Equity
2.87
+138.44%
-7.47
-161.86%
12.07
-27.73%
16.70
Capital Stock
0.00
+9966.67%
0.00
-99.99%
0.41
+196669.23%
0.00
Common Stock
0.00
+9966.67%
0.00
-85.91%
0.00
+43.27%
0.00
Preferred Stock
0.00
0.00
-100.00%
0.41
0.00
Share Issued
42.28
+9940.87%
0.42
+251.95%
0.12
+43.86%
0.08
Ordinary Shares Number
42.28
+9940.87%
0.42
+251.95%
0.12
+43.86%
0.08
Additional Paid In Capital
114.16
+7.96%
105.74
-4.70%
110.96
+3.29%
107.43
Retained Earnings
-111.29
+1.69%
-113.21
-14.48%
-98.89
-9.00%
-90.73
Total Equity Gross Minority Interest
2.87
+138.44%
-7.47
-159.84%
12.48
-25.28%
16.70
Total Capitalization
2.87
+138.44%
-7.47
-138.62%
19.34
-22.93%
25.09
Working Capital
2.87
+126.75%
-10.73
-211.58%
9.62
+26.58%
7.60
Invested Capital
2.87
+138.44%
-7.47
-137.18%
20.08
-23.28%
26.18
Total Debt
—
7.39
-10.76%
8.28
-16.25%
9.88
Net Debt
—
3.54
—
0.05
Capital Lease Obligations
—
0.14
-47.60%
0.26
-35.14%
0.41
Net Tangible Assets
2.87
+138.44%
-7.47
-312.86%
3.51
-21.30%
4.46
Tangible Book Value
2.87
+138.44%
-7.47
-340.94%
3.10
-30.48%
4.46
Current Notes Payable
—
7.25
+526.75%
1.16
+6.14%
1.09
Derivative Product Liabilities
—
0.00
-100.00%
3.55
0.00
Interest Payable
—
0.33
0.00
—
Preferred Stock Equity
—
—
0.41
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-6.73
-158.72%
-2.60
+65.87%
-7.63
+40.41%
-12.80
Cash Flow From Continuing Operating Activities
-4.74
-16.99%
-4.05
+46.84%
-7.63
+40.41%
-12.80
Cash From Discontinued Operating Activities
-1.99
-237.19%
1.45
—
—
Net Income From Continuing Operations
2.47
+450.73%
-0.71
+91.36%
-8.16
+59.26%
-20.04
Depreciation Amortization Depletion
—
2.94
-13.80%
3.42
-40.25%
5.72
Depreciation
—
2.94
-13.80%
3.42
-40.25%
5.72
Depreciation And Amortization
—
2.94
-13.80%
3.42
-40.25%
5.72
Other Non Cash Items
—
0.27
-97.57%
11.09
+448.83%
-3.18
Stock Based Compensation
0.30
+54.47%
0.20
-52.73%
0.42
-65.09%
1.20
Provisionand Write Offof Assets
—
-0.05
+31.77%
-0.07
-262.61%
-0.02
Asset Impairment Charge
—
7.38
+26026.71%
0.03
-99.61%
7.29
Deferred Tax
—
—
—
—
Deferred Income Tax
—
—
—
—
Operating Gains Losses
-6.86
-93.17%
-3.55
+76.28%
-14.97
-3154.13%
-0.46
Gain Loss On Investment Securities
0.12
+103.26%
-3.55
+76.28%
-14.97
-3154.13%
-0.46
Change In Working Capital
-0.66
-148.91%
-0.27
-142.66%
0.62
+118.92%
-3.30
Change In Receivables
—
1.82
+1361.79%
-0.14
-127.94%
0.52
Changes In Account Receivables
—
1.82
+1361.79%
-0.14
-127.94%
0.52
Change In Inventory
—
0.31
+12.42%
0.27
+132.76%
-0.84
Change In Prepaid Assets
-0.03
-173.61%
0.04
+103.65%
-0.97
-158.72%
1.65
Change In Payables And Accrued Expense
-0.64
-111.19%
-0.30
-118.50%
1.63
+135.84%
-4.55
Change In Accrued Expense
0.04
+106.55%
-0.65
-137.88%
1.73
+195.73%
-1.80
Change In Payable
-0.68
-293.44%
0.35
+477.63%
-0.09
+96.61%
-2.75
Change In Account Payable
-0.68
-293.44%
0.35
+477.63%
-0.09
+96.61%
-2.75
Change In Other Working Capital
—
-0.12
+28.57%
-0.16
—
Change In Other Current Liabilities
—
-0.36
-7358.46%
-0.00
+93.72%
-0.08
Investing Cash Flow
0.00
+100.00%
-0.02
0.00
—
Cash Flow From Continuing Investing Activities
—
-0.02
0.00
—
Cash From Discontinued Investing Activities
0.00
+100.00%
-0.02
—
—
Net PPE Purchase And Sale
—
-0.02
0.00
—
Purchase Of PPE
—
-0.02
0.00
—
Capital Expenditure
—
-0.02
—
—
Gain Loss On Sale Of Business
-6.97
0.00
—
—
Financing Cash Flow
8.16
+216.60%
-7.00
-160.67%
11.54
+810.43%
-1.62
Cash Flow From Continuing Financing Activities
8.16
+216.60%
-7.00
-160.67%
11.54
+810.43%
-1.62
Net Issuance Payments Of Debt
0.00
+100.00%
-0.77
+47.72%
-1.46
+9.86%
-1.62
Issuance Of Debt
—
—
—
—
Repayment Of Debt
0.00
+100.00%
-0.77
+47.72%
-1.46
+9.86%
-1.62
Long Term Debt Issuance
—
—
—
—
Long Term Debt Payments
0.00
+100.00%
-0.77
+47.72%
-1.46
+9.86%
-1.62
Net Long Term Debt Issuance
0.00
+100.00%
-0.77
+47.72%
-1.46
+9.86%
-1.62
Net Common Stock Issuance
8.50
0.00
—
0.00
Repurchase Of Capital Stock
-0.34
+94.52%
-6.23
-211.88%
-2.00
0.00
Proceeds From Stock Option Exercised
—
—
—
0.00
Net Other Financing Charges
—
—
15.00
—
Changes In Cash
1.43
+114.82%
-9.63
-346.17%
3.91
+127.12%
-14.42
Beginning Cash Position
3.71
-72.18%
13.34
+41.49%
9.43
-60.47%
23.85
End Cash Position
5.14
+38.46%
3.71
-72.18%
13.34
+41.49%
9.43
Free Cash Flow
-6.73
-158.72%
-2.60
+65.87%
-7.63
+40.41%
-12.80
Interest Paid Supplemental Data
0.00
0.00
-100.00%
0.54
-10.05%
0.60
Common Stock Issuance
8.50
0.00
—
0.00
Issuance Of Capital Stock
8.50
0.00
—
0.00
Net Preferred Stock Issuance
-0.34
+94.52%
-6.23
-211.88%
-2.00
0.00
Preferred Stock Payments
-0.34
+94.52%
-6.23
-211.88%
-2.00
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category